Dean Schorno
Direttore Finanziario/CFO presso RIGEL PHARMACEUTICALS, INC.
Patrimonio netto: 443 180 $ in data 30/04/2024
Posizioni attive di Dean Schorno
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| RIGEL PHARMACEUTICALS, INC. | Direttore Finanziario/CFO | 29/05/2018 | - |
Storia della carriera di Dean Schorno
Precedenti posizioni note di Dean Schorno
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
23andMe, Inc.
 23andMe, Inc. Medical SpecialtiesHealth Technology 23andMe, Inc. provides genetic information using DNA analysis technologies and web-based interactive tools. It enables individuals to gain deeper insights into personal ancestry, genealogy, and inherited traits. The company was founded by Linda Avey, Paul L. Cusenza and Anne E. Wojcicki in 2006 and is headquartered in Sunnyvale, CA. | Direttore operativo | 17/08/2015 | 01/05/2018 |
| Direttore Finanziario/CFO | 17/08/2015 | 01/05/2018 | |
| ADAPTIVE BIOTECHNOLOGIES CORPORATION | Direttore Finanziario/CFO | 24/06/2014 | 10/08/2015 |
| GENOMIC HEALTH, INC. | Direttore Finanziario/CFO | 10/01/2011 | 01/07/2014 |
| Contatto Relazioni con gli Investitori | 01/07/2003 | 01/07/2014 | |
| Public Communications Contact | 01/07/2003 | 01/07/2014 | |
| Corporate Officer/Principal | 01/02/2010 | 10/01/2011 |
Formazione di Dean Schorno
| University of California, Berkeley | Undergraduate Degree |
| Golden Gate University | Graduate Degree |
Statistiche
Distribuzione geografica
| Stati Uniti | 7 |
Posizioni
| Director of Finance/CFO | 4 |
| Investor Relations Contact | 1 |
| Public Communications Contact | 1 |
Settori
| Health Technology | 5 |
| Consumer Services | 3 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Società quotate in Borsa | 2 |
|---|---|
| ADAPTIVE BIOTECHNOLOGIES CORPORATION | Health Technology |
| RIGEL PHARMACEUTICALS, INC. | Health Technology |
| Aziende private | 2 |
|---|---|
Genomic Health, Inc.
 Genomic Health, Inc. Medical SpecialtiesHealth Technology Genomic Health, Inc. engages in the provision of genomic-based diagnostic tests. Its tests analyze the underlying biology of cancers, allowing physicians and patients to make individualized treatment decisions. The firm uses a platform which translates a massive amount of clinical and genomic data into clinically actionable results for treatment planning. The company was founded by Patrick F. Terry, Joffre B. Baker, Randal W. Scott, and Steven Shak in August 2000 and is headquartered in Redwood City, CA. | Health Technology |
23andMe, Inc.
23andMe, Inc. Medical SpecialtiesHealth Technology 23andMe, Inc. provides genetic information using DNA analysis technologies and web-based interactive tools. It enables individuals to gain deeper insights into personal ancestry, genealogy, and inherited traits. The company was founded by Linda Avey, Paul L. Cusenza and Anne E. Wojcicki in 2006 and is headquartered in Sunnyvale, CA. | Health Technology |
- Borsa valori
- Insiders
- Dean Schorno
- Esperienza
